220 related articles for article (PubMed ID: 9616147)
1. Ex vivo culture of CD34+/Lin-/DR- cells in stroma-derived soluble factors, interleukin-3, and macrophage inflammatory protein-1alpha maintains not only myeloid but also lymphoid progenitors in a novel switch culture assay.
Miller JS; McCullar V; Verfaillie CM
Blood; 1998 Jun; 91(12):4516-22. PubMed ID: 9616147
[TBL] [Abstract][Full Text] [Related]
2. A clinically suitable ex vivo expansion culture system for LTC-IC and CFC using stroma-conditioned medium.
Bhatia R; McGlave PB; Miller JS; Wissink S; Lin WN; Verfaillie CM
Exp Hematol; 1997 Aug; 25(9):980-91. PubMed ID: 9257812
[TBL] [Abstract][Full Text] [Related]
3. CD34+/CD33- cells reselected from macrophage inflammatory protein 1 alpha+interleukin-3--supplemented "stroma-noncontact" cultures are highly enriched for long-term bone marrow culture initiating cells.
Verfaillie CM; Miller JS
Blood; 1994 Sep; 84(5):1442-9. PubMed ID: 7520771
[TBL] [Abstract][Full Text] [Related]
4. Stromal factors support the expansion of the whole hemopoietic spectrum from bone marrow CD34+DR- cells and of some hemopoietic subsets from CD34+ and CD34+DR+ cells.
Herman P; Ferrant A; De Bruyère M; Straetmans N
Leukemia; 1998 May; 12(5):735-45. PubMed ID: 9593272
[TBL] [Abstract][Full Text] [Related]
5. Stromal fibroblast heparan sulfate is required for cytokine-mediated ex vivo maintenance of human long-term culture-initiating cells.
Gupta P; McCarthy JB; Verfaillie CM
Blood; 1996 Apr; 87(8):3229-36. PubMed ID: 8605338
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.
Kobari L; Pflumio F; Giarratana M; Li X; Titeux M; Izac B; Leteurtre F; Coulombel L; Douay L
Exp Hematol; 2000 Dec; 28(12):1470-80. PubMed ID: 11146169
[TBL] [Abstract][Full Text] [Related]
7. Macrophage inflammatory protein 1 alpha, interleukin 3 and diffusible marrow stromal factors maintain human hematopoietic stem cells for at least eight weeks in vitro.
Verfaillie CM; Catanzarro PM; Li WN
J Exp Med; 1994 Feb; 179(2):643-9. PubMed ID: 8294873
[TBL] [Abstract][Full Text] [Related]
8. Soluble factor(s) produced by human bone marrow stroma increase cytokine-induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiation.
Verfaillie CM
Blood; 1993 Oct; 82(7):2045-53. PubMed ID: 7691246
[TBL] [Abstract][Full Text] [Related]
9. Primitive long-term culture initiating cells (LTC-ICs) in granulocyte colony-stimulating factor mobilized peripheral blood progenitor cells have similar potential for ex vivo expansion as primitive LTC-ICs in steady state bone marrow.
Prosper F; Vanoverbeke K; Stroncek D; Verfaillie CM
Blood; 1997 Jun; 89(11):3991-7. PubMed ID: 9166837
[TBL] [Abstract][Full Text] [Related]
10. The generation of human natural killer cells from CD34+/DR- primitive progenitors in long-term bone marrow culture.
Miller JS; Verfaillie C; McGlave P
Blood; 1992 Nov; 80(9):2182-7. PubMed ID: 1384796
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of natural killer (NK) cells from human primitive marrow progenitors in a stroma-based long-term culture system: identification of a CD34+7+ NK progenitor.
Miller JS; Alley KA; McGlave P
Blood; 1994 May; 83(9):2594-601. PubMed ID: 7513206
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of interleukin-3, interleukin-7, interleukin 15, and granulocyte-macrophage colony-stimulating factor in the generation of natural killer and B cells from primitive human fetal liver progenitors.
Muench MO; Humeau L; Paek B; Ohkubo T; Lanier LL; Albanese CT; Bárcena A
Exp Hematol; 2000 Aug; 28(8):961-73. PubMed ID: 10989197
[TBL] [Abstract][Full Text] [Related]
13. Human LTC-IC can be maintained for at least 5 weeks in vitro when interleukin-3 and a single chemokine are combined with O-sulfated heparan sulfates: requirement for optimal binding interactions of heparan sulfate with early-acting cytokines and matrix proteins.
Gupta P; Oegema TR; Brazil JJ; Dudek AZ; Slungaard A; Verfaillie CM
Blood; 2000 Jan; 95(1):147-55. PubMed ID: 10607697
[TBL] [Abstract][Full Text] [Related]
14. Presence of primitive lymphoid progenitors with NK or B potential in ex vivo expanded bone marrow cell cultures.
Giarratana MC; Vergé V; Schmitt C; Bertho JM; Kobari L; Barret C; Douay L
Exp Hematol; 2000 Jan; 28(1):46-54. PubMed ID: 10658676
[TBL] [Abstract][Full Text] [Related]
15. A novel single-cell proliferation assay shows that long-term culture-initiating cell (LTC-IC) maintenance over time results from the extensive proliferation of a small fraction of LTC-IC.
Verfaillie CM; Miller JS
Blood; 1995 Sep; 86(6):2137-45. PubMed ID: 7662962
[TBL] [Abstract][Full Text] [Related]
16. Direct contact between CD34+lin- cells and stroma induces a soluble activity that specifically increases primitive hematopoietic cell production.
Koller MR; Oxender M; Jensen TC; Goltry KL; Smith AK
Exp Hematol; 1999 Apr; 27(4):734-41. PubMed ID: 10210331
[TBL] [Abstract][Full Text] [Related]
17. Can human hematopoietic stem cells be cultured ex vivo?
Verfaillie CM
Stem Cells; 1994 Sep; 12(5):466-76. PubMed ID: 7528589
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo expansion of CD34+/CD41+ late progenitors from enriched peripheral blood CD34+ cells.
Halle P; Rouzier C; Kanold J; Boiret N; Rapatel C; Mareynat G; Tchirkov A; Berger M; Travade P; Bonhomme J; Deméocq F
Ann Hematol; 2000 Jan; 79(1):13-9. PubMed ID: 10663616
[TBL] [Abstract][Full Text] [Related]
20. Multi-lineage expansion potential of primitive hematopoietic progenitors: superiority of umbilical cord blood compared to mobilized peripheral blood.
Lewis ID; Verfaillie CM
Exp Hematol; 2000 Sep; 28(9):1087-95. PubMed ID: 11008022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
